Senior Principal Scientist, Lab Head, Immunology, Cell Therapy
Genentech
Summary
The Department of Immunology Discovery at Genentech is excited to announce an opportunity for a Senior Principal Scientist, Lab Head, to lead a research group focused on designing next-generation cell therapies to treat autoimmune diseases.
Job description
The Opportunity
The Department of Immunology Discovery at Genentech is excited to announce an opportunity for a Senior Principal Scientist, Lab Head, to lead a research group focused on designing next-generation cell therapies to treat autoimmune diseases.
The successful candidate will lead a highly productive research team, integrating efforts across cross-functional teams to identify new targets and therapeutic hypotheses, and to advance transformative therapeutics from preclinical studies into early clinical development. The ideal candidate will have a deep understanding of cellular immunology principles and pathways relevant to the biology of autoimmune disease, including but not limited to inflammatory bowel disease, multiple sclerosis, lupus and chronic obstructive pulmonary disease. Excellent communication skills are essential to facilitate fruitful collaborations with colleagues across a diverse array of departments, including computational biology, proteomics and tissue genomics, drug development, early clinical development, and translational medicine.
Key Responsibilities
- Leading and managing a highly-productive research team
- Generating high-quality, original research that advances our understanding of autoimmune disease
- Contributing directly to the initiation and advancement of novel pipeline projects
- Playing a critical role within cross-functional teams evaluating external business development opportunities to accelerate our cell therapy pipeline
Who You Are
- PhD and postdoctoral training in Immunology, Cell Biology or related field
- A minimum of 10 years post-PhD experience with a record of high-impact publications (preprints considered), patents, and/or a proven track record advancing therapeutic candidates from pipeline entry to early clinical development and recognized as an established researcher in their field
- Demonstrated expertise in cellular immunology and a deep understanding of pathways and immune cell types that contribute to autoimmune disease
- Outstanding leadership and a collaborative spirit, with a proven track record of working with multidisciplinary teams
- Excellent written and verbal communication skills, with the ability to communicate complex scientific concepts to multidisciplinary audiences
- Exceptional critical thinking skills, a commitment to rigorous experimental design and creative problem-solving, and a demonstrated ability to use data-driven insights to guide scientific decisions
Preferred Qualifications
- Expertise in both B cell and T cell biology
- Experience engineering, modifying, and functionally evaluating human immune cells
- Experience working with mouse models, including humanized models
Requirements
- PhD and postdoctoral training in Immunology, Cell Biology or related field
- Minimum of 10 years post-PhD experience
- Record of high-impact publications, patents, and/or proven track record advancing therapeutic candidates from pipeline entry to early clinical development
- Recognized as an established researcher in their field
- Demonstrated expertise in cellular immunology and understanding of pathways and immune cell types contributing to autoimmune disease
- Outstanding leadership and collaborative spirit with proven track record working with multidisciplinary teams
- Excellent written and verbal communication skills
- Exceptional critical thinking skills and commitment to rigorous experimental design
- Demonstrated ability to use data-driven insights to guide scientific decisions
Benefits
- Relocation benefits
- Discretionary annual bonus
Company overview
Genentech, founded in 1976 and now a member of the Roche Group, is widely recognized as the pioneer of the biotechnology industry. The company has been at the forefront of scientific innovation for nearly 50 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. With over 10,000 employees, the company operates from its South San Francisco headquarters and maintains a strong focus on oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Genentech continues to pursue groundbreaking science while maintaining its startup spirit within the Roche organization, consistently delivering on its promise to improve patients' lives through innovative biopharmaceutical solutions.